Business

Zydus can sell anti-cancer drug Nivolumab biosimilarin India, says Delhi high court(Soban News)

The court directed Zydus to maintain detailed and audited records of its sales during this period so that the innovator can be compensated in case it ultimately succeeds in the patent infringement suit.

​The court directed Zydus to maintain detailed and audited records of its sales during this period so that the innovator can be compensated in case it ultimately succeeds in the patent infringement suit. by Soban News (international And National News)

Related posts

India’s chipmaking to be at par with major producers by 2032: Vaishnaw(Soban News)

News-Soban-Admin

Pakistan-Afghanistan clashes: Trump blames Islamabad; calls conflict ‘easy’ to solve – The Times of India(Soban News)

News-Soban-Admin

FedEx conducts India’s first intra-city drone delivery trials in Bengaluru(Soban News)

News-Soban-Admin

Leave a Comment